Earnings Summary

Charles River Laboratories International’s revenue fell -1.64% since last year same period to $1009.76Mn in the Q3 2024. On a quarterly growth basis, Charles River Laboratories International has generated -1.59% fall in its revenue since last 3-months.

Charles River Laboratories International’s net profit fell -21.41% since last year same period to $68.68Mn in the Q3 2024. On a quarterly growth basis, Charles River Laboratories International has generated -23.68% fall in its net profits since last 3-months.

Charles River Laboratories International’s net profit margin fell -20.1% since last year same period to 6.8% in the Q3 2024. On a quarterly growth basis, Charles River Laboratories International has generated -22.44% fall in its net profit margins since last 3-months.

Charles River Laboratories International’s earning per share (EPS) estimates for the current quarter stand at 2.43 - a 1.67% jump from last quarter’s estimates.

Charles River Laboratories International’s earning per share (EPS) estimates for the current year stand at 2.43.

Charles River Laboratories International’s earning per share (EPS) fell -4.78% since last year same period to 2.59 in the Q3 2024. This indicates that the Charles River Laboratories International has generated -4.78% annual rate of fall in its earning per share (EPS) in the last 4 quarters.